Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment.

Rotoli D, Morales M, Maeso MD, Avila J, Pérez-Rodríguez ND, Mobasheri A, van Noorden CJF, Martín-Vasallo P.

J Histochem Cytochem. 2019 Feb 22:22155419833334. doi: 10.1369/0022155419833334. [Epub ahead of print]

PMID:
30794467
2.

Expression patterns of endothelial permeability pathways in the development of the blood-retinal barrier in mice.

van der Wijk AE, Wisniewska-Kruk J, Vogels IMC, van Veen HA, Ip WF, van der Wel NN, van Noorden CJF, Schlingemann RO, Klaassen I.

FASEB J. 2019 Apr;33(4):5320-5333. doi: 10.1096/fj.201801499RRR. Epub 2019 Jan 30.

3.

Comparison of different methodologies and cryostat versus paraffin sections for chromogenic immunohistochemistry.

Hira VVV, de Jong AL, Ferro K, Khurshed M, Molenaar RJ, Van Noorden CJF.

Acta Histochem. 2019 Feb;121(2):125-134. doi: 10.1016/j.acthis.2018.10.011. Epub 2018 Nov 16.

4.

Localization patterns of cathepsins K and X and their predictive value in glioblastoma.

Breznik B, Limback C, Porcnik A, Blejec A, Krajnc MK, Bosnjak R, Kos J, Van Noorden CJF, Lah TT.

Radiol Oncol. 2018 Oct 18;52(4):433-442. doi: 10.2478/raon-2018-0040.

5.

Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature.

Kastelein AW, Vos LMC, de Jong KH, van Baal JOAM, Nieuwland R, van Noorden CJF, Roovers JWR, Lok CAR.

Semin Cell Dev Biol. 2018 Oct 8. pii: S1084-9521(18)30019-3. doi: 10.1016/j.semcdb.2018.09.007. [Epub ahead of print] Review.

PMID:
30253239
6.
7.

Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.

van der Wijk AE, Canning P, van Heijningen RP, Vogels IMC, van Noorden CJF, Klaassen I, Schlingemann RO.

Acta Ophthalmol. 2019 Mar;97(2):214-224. doi: 10.1111/aos.13909. Epub 2018 Aug 31.

PMID:
30168271
8.

Correction: Wild-type and mutated IDH1/2 enzymes and therapy responses.

Molenaar RJ, Maciejewski JP, Wilmink JW, van Noorden CJF.

Oncogene. 2018 Oct;37(43):5810. doi: 10.1038/s41388-018-0455-1.

PMID:
30140044
9.

Cysteine cathepsins B, X and K expression in peri-arteriolar glioblastoma stem cell niches.

Breznik B, Limbaeck Stokin C, Kos J, Khurshed M, Hira VVV, Bošnjak R, Lah TT, Van Noorden CJF.

J Mol Histol. 2018 Oct;49(5):481-497. doi: 10.1007/s10735-018-9787-y. Epub 2018 Jul 25.

10.

Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.

Lenting K, Khurshed M, Peeters TH, van den Heuvel CNAM, van Lith SAM, de Bitter T, Hendriks W, Span PN, Molenaar RJ, Botman D, Verrijp K, Heerschap A, Ter Laan M, Kusters B, van Ewijk A, Huynen MA, van Noorden CJF, Leenders WPJ.

FASEB J. 2019 Jan;33(1):557-571. doi: 10.1096/fj.201800907RR. Epub 2018 Jul 12.

PMID:
30001166
11.

IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers.

Dallinga MG, Yetkin-Arik B, Kayser RP, Vogels IMC, Nowak-Sliwinska P, Griffioen AW, van Noorden CJF, Klaassen I, Schlingemann RO.

Angiogenesis. 2018 Nov;21(4):823-836. doi: 10.1007/s10456-018-9627-4. Epub 2018 Jun 27.

12.

Metabolic Mapping: Quantitative Enzyme Cytochemistry and Histochemistry to Determine the Activity of Dehydrogenases in Cells and Tissues.

Molenaar RJ, Khurshed M, Hira VVV, Van Noorden CJF.

J Vis Exp. 2018 May 26;(135). doi: 10.3791/56843.

13.

IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity.

Khurshed M, Aarnoudse N, Hulsbos R, Hira VVV, van Laarhoven HWM, Wilmink JW, Molenaar RJ, van Noorden CJF.

FASEB J. 2018 Jun 7:fj201800547R. doi: 10.1096/fj.201800547R. [Epub ahead of print]

14.

Spatial and temporal recruitment of the neurovascular unit during development of the mouse blood-retinal barrier.

van der Wijk AE, Vogels IMC, van Veen HA, van Noorden CJF, Schlingemann RO, Klaassen I.

Tissue Cell. 2018 Jun;52:42-50. doi: 10.1016/j.tice.2018.03.010. Epub 2018 Mar 23.

15.

The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.

Aderetti DA, Hira VVV, Molenaar RJ, van Noorden CJF.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):346-354. doi: 10.1016/j.bbcan.2018.04.008. Epub 2018 Apr 21. Review.

16.

Effects of the Green Tea Polyphenol Epigallocatechin-3-Gallate on Glioma: A Critical Evaluation of the Literature.

Le CT, Leenders WPJ, Molenaar RJ, van Noorden CJF.

Nutr Cancer. 2018 Apr;70(3):317-333. doi: 10.1080/01635581.2018.1446090. Epub 2018 Mar 23. Review.

PMID:
29570984
17.

Development of calcium bodies in Hylonsicus riparius (Crustacea: Isopoda).

Vittori M, Khurshed M, Picavet DI, van Noorden CJF, Štrus J.

Arthropod Struct Dev. 2018 Mar;47(2):199-213. doi: 10.1016/j.asd.2018.02.002. Epub 2018 Feb 15.

PMID:
29421154
18.

Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells.

Ramos de Carvalho JE, Verwoert MT, Vogels IMC, Reits EA, Van Noorden CJF, Klaassen I, Schlingemann RO.

Biochem Biophys Rep. 2018 Jan 28;13:83-92. doi: 10.1016/j.bbrep.2018.01.005. eCollection 2018 Mar.

19.

Wild-type and mutated IDH1/2 enzymes and therapy responses.

Molenaar RJ, Maciejewski JP, Wilmink JW, van Noorden CJF.

Oncogene. 2018 Apr;37(15):1949-1960. doi: 10.1038/s41388-017-0077-z. Epub 2018 Jan 25. Review. Erratum in: Oncogene. 2018 Oct;37(43):5810.

20.

IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors.

Molenaar RJ, Radivoyevitch T, Nagata Y, Khurshed M, Przychodzen B, Makishima H, Xu M, Bleeker FE, Wilmink JW, Carraway HE, Mukherjee S, Sekeres MA, van Noorden CJF, Maciejewski JP.

Clin Cancer Res. 2018 Apr 1;24(7):1705-1715. doi: 10.1158/1078-0432.CCR-17-2796. Epub 2018 Jan 16.

21.

Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar.

Hira VVV, Aderetti DA, van Noorden CJF.

J Histochem Cytochem. 2018 May;66(5):349-358. doi: 10.1369/0022155417752676. Epub 2018 Jan 12.

22.

Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.

Hira VVV, Wormer JR, Kakar H, Breznik B, van der Swaan B, Hulsbos R, Tigchelaar W, Tonar Z, Khurshed M, Molenaar RJ, Van Noorden CJF.

J Histochem Cytochem. 2018 Mar;66(3):155-173. doi: 10.1369/0022155417749174. Epub 2018 Jan 3.

23.

Efficacy of photodynamic therapy as adjunct treatment of chronic periodontitis: a systematic review and meta-analysis.

Azaripour A, Dittrich S, Van Noorden CJF, Willershausen B.

Lasers Med Sci. 2018 Feb;33(2):407-423. doi: 10.1007/s10103-017-2383-7. Epub 2017 Nov 25. Review.

PMID:
29177555
24.

Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

van Baal JOAM, van Noorden CJF, Nieuwland R, Van de Vijver KK, Sturk A, van Driel WJ, Kenter GG, Lok CAR.

J Histochem Cytochem. 2018 Feb;66(2):67-83. doi: 10.1369/0022155417742897. Epub 2017 Nov 22.

25.

Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.

Klaassen I, de Vries EW, Vogels IMC, van Kampen AHC, Bosscha MI, Steel DHW, Van Noorden CJF, Lesnik-Oberstein SY, Schlingemann RO.

PLoS One. 2017 Nov 2;12(11):e0187304. doi: 10.1371/journal.pone.0187304. eCollection 2017.

26.

Modulation of the Proteasome Pathway by Nano-Curcumin and Curcumin in Retinal Pigment Epithelial Cells.

Ramos de Carvalho JE, Verwoert MT, Vogels IMC, Schipper-Krom S, Van Noorden CJF, Reits EA, Klaassen I, Schlingemann RO.

Ophthalmic Res. 2018;59(2):98-109. doi: 10.1159/000481261. Epub 2017 Oct 27.

PMID:
29073609
27.

Comparison of Spectrophotometry, Chromate Inhibition, and Cytofluorometry Versus Gene Sequencing for Detection of Heterozygously Glucose-6-Phosphate Dehydrogenase-Deficient Females.

Peters AL, Veldthuis M, van Leeuwen K, Bossuyt PMM, Vlaar APJ, van Bruggen R, de Korte D, Van Noorden CJF, van Zwieten R.

J Histochem Cytochem. 2017 Nov;65(11):627-636. doi: 10.1369/0022155417730021. Epub 2017 Sep 13.

28.

Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?

van der Wijk AE, Hughes JM, Klaassen I, Van Noorden CJF, Schlingemann RO.

J Leukoc Biol. 2017 Oct;102(4):993-1001. doi: 10.1189/jlb.3RU0417-139. Epub 2017 Jul 19. Review.

PMID:
28724696
29.

TNFα-Induced Disruption of the Blood-Retinal Barrier In Vitro Is Regulated by Intracellular 3',5'-Cyclic Adenosine Monophosphate Levels.

van der Wijk AE, Vogels IMC, van Noorden CJF, Klaassen I, Schlingemann RO.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3496-3505. doi: 10.1167/iovs.16-21091.

PMID:
28715583
30.

Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours.

Molenaar RJ, Coelen RJS, Khurshed M, Roos E, Caan MWA, van Linde ME, Kouwenhoven M, Bramer JAM, Bovée JVMG, Mathôt RA, Klümpen HJ, van Laarhoven HWM, van Noorden CJF, Vandertop WP, Gelderblom H, van Gulik TM, Wilmink JW.

BMJ Open. 2017 Jun 10;7(6):e014961. doi: 10.1136/bmjopen-2016-014961.

31.

In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.

Khurshed M, Molenaar RJ, Lenting K, Leenders WP, van Noorden CJF.

Oncotarget. 2017 Jul 25;8(30):49165-49177. doi: 10.18632/oncotarget.17106.

32.

Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.

Hira VVV, Van Noorden CJF, Carraway HE, Maciejewski JP, Molenaar RJ.

Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):183-198. doi: 10.1016/j.bbcan.2017.03.010. Epub 2017 Mar 28. Review.

33.

Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes.

Peters AL, van Noorden CJ.

Methods Mol Biol. 2017;1560:3-13. doi: 10.1007/978-1-4939-6788-9_1. Review.

PMID:
28155142
34.

Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells.

Hira VV, Verbovšek U, Breznik B, Srdič M, Novinec M, Kakar H, Wormer J, der Swaan BV, Lenarčič B, Juliano L, Mehta S, Van Noorden CJ, Lah TT.

Biochim Biophys Acta Mol Cell Res. 2017 Mar;1864(3):594-603. doi: 10.1016/j.bbamcr.2016.12.021. Epub 2016 Dec 28.

35.

The hypoxanthine-xanthine oxidase axis is not involved in the initial phase of clinical transplantation-related ischemia-reperfusion injury.

Wijermars LG, Bakker JA, de Vries DK, van Noorden CJ, Bierau J, Kostidis S, Mayboroda OA, Tsikas D, Schaapherder AF, Lindeman JH.

Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F457-F464. doi: 10.1152/ajprenal.00214.2016. Epub 2016 Dec 28.

36.

Correction: CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.

Siemerink MJ, Hughes MR, Dallinga MG, Gora T, Cait J, Vogels IM, Yetkin-Arik B, Van Noorden CJ, Klaassen I, McNagny KM, Schlingemann RO.

PLoS One. 2016 Dec 21;11(12):e0169061. doi: 10.1371/journal.pone.0169061. eCollection 2016.

37.

The histophysiology and pathophysiology of the peritoneum.

van Baal JO, Van de Vijver KK, Nieuwland R, van Noorden CJ, van Driel WJ, Sturk A, Kenter GG, Rikkert LG, Lok CA.

Tissue Cell. 2017 Feb;49(1):95-105. doi: 10.1016/j.tice.2016.11.004. Epub 2016 Nov 13. Review.

PMID:
27890350
38.

Root coverage with connective tissue graft associated with coronally advanced flap or tunnel technique: a randomized, double-blind, mono-centre clinical trial.

Azaripour A, Kissinger M, Farina VS, Van Noorden CJ, Gerhold-Ay A, Willershausen B, Cortellini P.

J Clin Periodontol. 2016 Dec;43(12):1142-1150. doi: 10.1111/jcpe.12627. Epub 2016 Oct 25.

PMID:
27716979
39.

Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma.

van Lith SA, Navis AC, Lenting K, Verrijp K, Schepens JT, Hendriks WJ, Schubert NA, Venselaar H, Wevers RA, van Rooij A, Wesseling P, Molenaar RJ, van Noorden CJ, Pusch S, Tops B, Leenders WP.

Sci Rep. 2016 Jul 27;6:30486. doi: 10.1038/srep30486.

40.

CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.

Siemerink MJ, Hughes MR, Dallinga MG, Gora T, Cait J, Vogels IM, Yetin-Arik B, Van Noorden CJ, Klaassen I, McNagny KM, Schlingemann RO.

PLoS One. 2016 Jun 28;11(6):e0157902. doi: 10.1371/journal.pone.0157902. eCollection 2016. Erratum in: PLoS One. 2016 Dec 21;11(12 ):e0169061.

41.

Efficacy of an aluminium triformate mouthrinse during the maintenance phase in periodontal patients: a pilot double blind randomized placebo-controlled clinical trial.

Azaripour A, Weusmann J, Eschig C, Schmidtmann I, Van Noorden CJ, Willershausen B.

BMC Oral Health. 2016 May 23;16(1):57. doi: 10.1186/s12903-016-0214-z.

42.

A survey of clearing techniques for 3D imaging of tissues with special reference to connective tissue.

Azaripour A, Lagerweij T, Scharfbillig C, Jadczak AE, Willershausen B, Van Noorden CJ.

Prog Histochem Cytochem. 2016 Aug;51(2):9-23. doi: 10.1016/j.proghi.2016.04.001. Epub 2016 Apr 14. Review.

43.

Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.

Wisniewska-Kruk J, van der Wijk AE, van Veen HA, Gorgels TG, Vogels IM, Versteeg D, Van Noorden CJ, Schlingemann RO, Klaassen I.

Am J Pathol. 2016 Apr;186(4):1044-54. doi: 10.1016/j.ajpath.2015.11.019. Epub 2016 Feb 12.

PMID:
26878208
44.

Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.

Nijland PG, Molenaar RJ, van der Pol SM, van der Valk P, van Noorden CJ, de Vries HE, van Horssen J.

Acta Neuropathol Commun. 2015 Dec 4;3:79. doi: 10.1186/s40478-015-0261-8.

45.

Correction: Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma.

Verbovšek U, Motaln H, Rotter A, Atai NA, Gruden K, Van Noorden CJ, Lah TT.

PLoS One. 2015 Oct 29;10(10):e0142116. doi: 10.1371/journal.pone.0142116. eCollection 2015. No abstract available.

46.

Glucose-6-phosphate dehydrogenase activity decreases during storage of leukoreduced red blood cells.

Peters AL, van Bruggen R, de Korte D, Van Noorden CJ, Vlaar AP.

Transfusion. 2016 Feb;56(2):427-32. doi: 10.1111/trf.13378. Epub 2015 Oct 12.

PMID:
26456480
47.

Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198.

Molenaar RJ, Botman D, Smits MA, Hira VV, van Lith SA, Stap J, Henneman P, Khurshed M, Lenting K, Mul AN, Dimitrakopoulou D, van Drunen CM, Hoebe RA, Radivoyevitch T, Wilmink JW, Maciejewski JP, Vandertop WP, Leenders WP, Bleeker FE, van Noorden CJ.

Cancer Res. 2015 Nov 15;75(22):4790-802. doi: 10.1158/0008-5472.CAN-14-3603. Epub 2015 Sep 11.

48.

Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression.

Verbovšek U, Van Noorden CJ, Lah TT.

Semin Cancer Biol. 2015 Dec;35:71-84. doi: 10.1016/j.semcancer.2015.08.010. Epub 2015 Aug 29. Review.

PMID:
26320409
49.

Braces versus Invisalign®: gingival parameters and patients' satisfaction during treatment: a cross-sectional study.

Azaripour A, Weusmann J, Mahmoodi B, Peppas D, Gerhold-Ay A, Van Noorden CJ, Willershausen B.

BMC Oral Health. 2015 Jun 24;15:69. doi: 10.1186/s12903-015-0060-4.

50.

Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms.

Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, Hirsh C, Viny AD, Hosano N, Bleeker FE, Meggendorfer M, Alpermann T, Shiraishi Y, Chiba K, Tanaka H, van Noorden CJ, Radivoyevitch T, Carraway HE, Makishima H, Miyano S, Sekeres MA, Ogawa S, Haferlach T, Maciejewski JP.

Leukemia. 2015 Nov;29(11):2134-42. doi: 10.1038/leu.2015.91. Epub 2015 Apr 3.

Supplemental Content

Loading ...
Support Center